The global insect cell expression market size was valued at USD 292.4 million in 2021 and is poised to grow at a significant CAGR of 12.4% during the forecast period 2022-2028. Increasing demand for the baculovirus-insect cell expression system utilizes recombinant baculoviruses (insect viruses) and has the capacity to produce many recombinant proteins at high levels and they also provide significant eukaryotic protein processing capabilities. An insect expression system is suitable for expressing intracellular proteins and multi-protein complexes. Moreover, other players are focusing on acquisition to maintain growth in the market. For instance, in April 2020, Thermo Fisher Scientific acquired Clinical Research Organisation PPD. This acquisition of PPD will aid Thermo Fisher in expanding service offering to pharma and biotech customers and establish the company as a global leader in the clinical research services sector.

View detailed report description at


The global insect cell expression market is segmentation:  

1) By product type: Reagents, Expression Vectors, Competent Cells, Instruments, Services.

2) By Application: Therapeutic Applications, Industrial Applications, Research Applications.


Product Type Segments are Dominate the Insect Cell Expression Market
Based on product type, the global insect cell expression market is segmented into reagents, expression vectors, competent cells, instruments, and services. Regents segment anticipated to hold largest market share owing to the process of protein expression include the use of reagents such as acids & bases, acrylamides, buffers, cell lysis of carbohydrates, detergents, general reagents, protease inhibitors and solvents. For research, industrial and pharmaceutical processing, these reagents have applications and expected that repetitive buying of reagents for different applications will boost market growth.

North America Leads Insect Cell Expression Market
Asia Pacific is expected to grow at the highest CAGR over the forecast years owing to rapid growth in the geriatric population most prone for chronic diseases in Japan, China, and India coupled with a surge in the R&D in academic and research institutes across the region. Moreover, the Rise in funding from public and private sectors for insect cell expression and protein expression analysis also significantly enhance the revenue of the market over the forecast years. Furthermore, players and academic research institutes are focusing on collaboration to maintain the growth in the market. For instance, in January 2020, Merck KGaA announced the opening of a high-tech skill development center in collaboration with the Council of Scientific and Industrial Research’s Institute of Microbial Technology (CSIR-IMTECH), an organization under the government of India’s Ministry of Science and Technology.

Global Insect Cell Expression market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In 2021, Thermo Fisher Scinetific (US) acquired Phitonex (US). The acquisition will allow Thermo Fisher to provide greater flow cytometry and imaging multiplexing capabilities for protein and cell analysis research needs. 

Request sample report at  

Key players’ in the insect cell expression market report are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), GenScript Biotech Corporation (US), Agilent Technologies Inc. (US), Takara Bio, Inc. (Japan), Bio-RadLaboratoriesInc.(US), Lonza (Switzerland), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (UK), LifeSensors (US), ProteoGenix (US), Synthetic Genomics Inc. (US), Peak Proteins Ltd. (UK).


About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.



Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747